Korean Drug Co. Ltd (014570) — Tangible Net Worth Ratio
Korean Drug Co. Ltd (014570) has a Tangible Net Worth Ratio of 99.7% as of June 2026. This metric is calculated by deducting intangible assets (₩208.62 Million) from net assets (₩78.82 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Korean Drug Co. Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Korean Drug Co. Ltd Tangible Net Worth Ratio (2014–2025)
This chart shows how Korean Drug Co. Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 99.7%, reflecting net assets of ₩78.82 Billion with intangible assets of ₩208.62 Million KRW. For live market cap and overall valuation, see Korean Drug Co. Ltd market cap and net worth.
Annual Tangible Net Worth Ratio for Korean Drug Co. Ltd (2014–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Korean Drug Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Korean Drug Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | ₩83.07 Billion | ₩208.77 Million | ₩94.32 Billion | ▲ +0.0 pp |
| 2024 | 99.7% | ₩78.11 Billion | ₩220.02 Million | ₩88.89 Billion | ▲ +0.2 pp |
| 2023 | 99.5% | ₩77.09 Billion | ₩362.80 Million | ₩89.71 Billion | ▲ +0.1 pp |
| 2022 | 99.4% | ₩84.71 Billion | ₩501.66 Million | ₩94.52 Billion | ▼ -0.2 pp |
| 2021 | 99.6% | ₩76.69 Billion | ₩274.13 Million | ₩88.61 Billion | ▲ +0.6 pp |
| 2020 | 99.0% | ₩70.87 Billion | ₩683.89 Million | ₩83.34 Billion | ▲ +0.1 pp |
| 2019 | 99.0% | ₩65.05 Billion | ₩661.22 Million | ₩75.85 Billion | ▲ +0.2 pp |
| 2018 | 98.8% | ₩62.80 Billion | ₩758.14 Million | ₩72.96 Billion | ▲ +0.3 pp |
| 2017 | 98.5% | ₩56.97 Billion | ₩834.26 Million | ₩66.79 Billion | ▲ +0.0 pp |
| 2016 | 98.5% | ₩53.66 Billion | ₩795.65 Million | ₩63.41 Billion | ▲ +0.3 pp |
| 2015 | 98.2% | ₩49.68 Billion | ₩891.97 Million | ₩59.20 Billion | ▼ -0.3 pp |
| 2014 | 98.5% | ₩48.79 Billion | ₩745.73 Million | ₩62.17 Billion | — |